Text-based Intervention for Breast Cancer

Recruiting in Palo Alto (17 mi)

+6 other locations

Overseen byKuang-Yi Wen, MD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Thomas Jefferson University

Stay on Your Current Meds

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial studies how well a text-based intervention works in improving adherence to hormone therapy in patients with stage I-III hormone receptor positive breast cancer. Women often require long term therapy with adjuvant hormone therapy to prevent the cancer from returning and to improve overall survival. Side effects from hormone therapy may prevent some women from staying adherent to their medication therapy. A text-based intervention may provide educational information to breast cancer patients who are undergoing adjuvant hormone therapy.

Eligibility Criteria

This trial is for women within 3 months of starting a new hormone therapy after being diagnosed with stage I-III hormone receptor positive breast cancer. Participants must be recommended to undergo at least 12 months of therapy, know how to text or willing to learn, have completed their initial treatments like surgery and chemotherapy, understand English, consent to the study, and own a mobile device that can send texts.

Inclusion Criteria

Know or willing to learn how to use TXT

My tumor is hormone receptor positive.

I have finished all my initial cancer treatments.

+6 more

Exclusion Criteria

You have a recorded cognitive impairment in your medical records.

Participant Groups

The trial is testing whether sending educational text messages can help women stick to their long-term hormone therapy regimen for early-stage breast cancer. It aims to see if this support improves adherence when side effects might otherwise discourage them from continuing treatment.

3Treatment groups

Experimental Treatment

Active Control

Group I: Phase II Group 1 (text messages)Experimental Treatment2 Interventions

Participants receive text messages twice weekly for 6 months to remind and motivate participants about AHT adherence.

Group II: Phase 1 (focus groups)Experimental Treatment2 Interventions

Participants attend focus groups on adherence to hormone therapy.

Group III: Phase II Group II (usual care)Active Control2 Interventions

Participants receive usual care.